121 related articles for article (PubMed ID: 177440)
1. Acute administration of 25-hydroxycholecalciferol in man.
Haddad JG; Rojanasathit S
J Clin Endocrinol Metab; 1976 Feb; 42(2):284-90. PubMed ID: 177440
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of orally administered [3H]ergocalciferol and [3H]cholecalciferol by dairy calves.
Sommerfeldt JL; Napoli JL; Littledike ET; Beitz DC; Horst RL
J Nutr; 1983 Dec; 113(12):2595-600. PubMed ID: 6317829
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D bioavailability: serum 25-hydroxyvitamin D levels in man after oral, subcutaneous, intramuscular, and intravenous vitamin D administration.
Whyte MP; Haddad JG; Walters DD; Stamp TC
J Clin Endocrinol Metab; 1979 Jun; 48(6):906-11. PubMed ID: 447796
[TBL] [Abstract][Full Text] [Related]
4. [Behavior of serum 25-hydroxycholecalciferol in humans after administration of vitamin D and 25-OHD3].
Coen G; Taccone Gallucci M; Bianchini G; Lucentini G; Gallucci G; Bianchi AR; Matteucci MC; Picca S; Casciani CU
Boll Soc Ital Biol Sper; 1979 Oct; 55(20):2051-6. PubMed ID: 232847
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of 5,6-trans-25-hydroxycholecalciferol, a synthetic analogue of vitamin D3, in man.
Offermann G; Schaefer K; Grigoleit HG; Dittmar F
Eur J Clin Pharmacol; 1975 Apr; 8(3-4):255-60. PubMed ID: 1233221
[TBL] [Abstract][Full Text] [Related]
6. Human serum binding capacity and affinity for 25-hydroxyergocalciferol and 25-hydroxycholecalciferol.
Haddad JG; Hillman L; Rojanasathit S
J Clin Endocrinol Metab; 1976 Jul; 43(1):86-91. PubMed ID: 1084889
[TBL] [Abstract][Full Text] [Related]
7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
8. Comparison of oral 25-hydroxycholecalciferol, vitamin D, and ultraviolet light as determinants of circulating 25-hydroxyvitamin D.
Stamp TC; Haddad JG; Twigg CA
Lancet; 1977 Jun; 1(8026):1341-3. PubMed ID: 69059
[TBL] [Abstract][Full Text] [Related]
9. Concentration of 25-hydroxyvitamin D in serum of infants under the intermittent high-dose vitamin D3 prophylactic treatment.
Pietrek J; Otto-Buczkowska E; Kokot F; Karpiel R; Cekański A
Arch Immunol Ther Exp (Warsz); 1980; 28(5):805-14. PubMed ID: 6260055
[TBL] [Abstract][Full Text] [Related]
10. Hepatic accumulation of vitamin D3 and 25-hydroxyvitamin D3.
Rojanasathit S; Haddad JG
Biochim Biophys Acta; 1976 Jan; 421(1):12-21. PubMed ID: 174734
[TBL] [Abstract][Full Text] [Related]
11. Treatment of hypoparathyroidism and pseudohypoparathyroidism with metabolites of vitamin D: evidence for impaired conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D.
Kooh SW; Fraser D; DeLuca HF; Holick MF; Belsey RE; Clark MB; Murray TM
N Engl J Med; 1975 Oct; 293(17):840-4. PubMed ID: 170516
[TBL] [Abstract][Full Text] [Related]
12. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol.
Heaney RP; Davies KM; Chen TC; Holick MF; Barger-Lux MJ
Am J Clin Nutr; 2003 Jan; 77(1):204-10. PubMed ID: 12499343
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and amounts of 25-hydroxycholecalciferol in sheep affected by osteodystrophy.
Hidiroglou M; Williams CJ; Ivan M
J Dairy Sci; 1979 Apr; 62(4):567-71. PubMed ID: 222820
[TBL] [Abstract][Full Text] [Related]
14. The absence of 24,25-dihydroxycholecalciferol in anephric patients.
Taylor CM; Mawer EB; Wallace JE; St John J; Cochran M; Russell RG; Kanis JA
Clin Sci Mol Med Suppl; 1978 Dec; 55(6):541-7. PubMed ID: 216522
[TBL] [Abstract][Full Text] [Related]
15. 25-Hydroxycholecalciferol inthe management of rickets associated with extrahepatic biliary atresia.
Daum F; Rosen JF; Roginsky M; Cohen MI; Finberg L
J Pediatr; 1976 Jun; 88(6):1041-3. PubMed ID: 178851
[TBL] [Abstract][Full Text] [Related]
16. Cats discriminate between cholecalciferol and ergocalciferol.
Morris JG
J Anim Physiol Anim Nutr (Berl); 2002 Aug; 86(7-8):229-38. PubMed ID: 15379909
[TBL] [Abstract][Full Text] [Related]
17. Changes in plasma 25-hydroxycholecalciferol and selected blood parameters after injection of massive doses of cholecalciferol or 25-hydroxycholecalciferol in non-lactating dairy cows.
Hollis BW; Conrad HR; Hibbs JW
J Nutr; 1977 Apr; 107(4):606-13. PubMed ID: 191582
[TBL] [Abstract][Full Text] [Related]
18. The turnover and transport of vitamin D and of a polar metabolite with the properties of 25-hydroxycholecalciferol in human plasma.
Smith JE; Goodman DS
J Clin Invest; 1971 Oct; 50(10):2159-67. PubMed ID: 4330006
[TBL] [Abstract][Full Text] [Related]
19. Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review.
Setnikar I; Rovati LC
Arzneimittelforschung; 2001 Sep; 51(9):699-725. PubMed ID: 11642003
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the appearance of radiolabelled vitamin D3 and 25-hydroxy-vitamin D3 in the chylomicron fraction of plasma after oral administration in man.
Compston JE; Merrett AL; Hammett FG; Magill P
Clin Sci (Lond); 1981 Feb; 60(2):241-3. PubMed ID: 6263539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
